Litcius/Paper detail

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Leonie Müller‐Jensen, Sarah Zierold, Judith M. Versluis, Wolfgang Boehmerle, Petra Huehnchen, Matthias Endres, Raphael Mohr, Annette Compter, Christian U. Blank, Tim Hagenacker, Friedegund Meier, Lydia Reinhardt, Anja Gesierich, Martin Salzmann, Jessica C. Hassel, Selma Ugurel, Lisa Zimmer, Patricia Banks, Lavinia Spain, J. Soon, Tomohiro Enokida, Makoto Tahara, Katharina C. Kähler, Ruth Seggewiß-Bernhardt, Catriona Harvey, Georgina V. Long, Florian Schöberl, Louisa von Baumgarten, Thomas Hundsberger, Max Schlaak, Lars E. French, Samuel Knauß, Lucie Heinzerling

2022European Journal of Cancer38 citationsDOIOpen Access PDF

Topics & Concepts

EncephalitisMedicineCSF pleocytosisInternal medicinePleocytosisAutoimmune encephalitisRetrospective cohort studyGliomaCohortGastroenterologyImmunologyCerebrospinal fluidVirusCancer researchAutoimmune Neurological Disorders and TreatmentsCancer Immunotherapy and BiomarkersBrain Metastases and Treatment
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study | Litcius